• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Austedo

Teva Pharmaceuticals
Pharma

Teva CEO touts 'defining strength' of innovative drugs

The company remains confident in the continued sales potential of Austedo after wrapping up IRA-mandated government pricing negotiations.
Zoey Becker Nov 5, 2025 2:25pm
Teva Pharmaceuticals The Other TD campaign

Teva drafts Terrell Davis for tardive dyskinesia awareness drive

Nov 5, 2025 12:49pm
Teva Pharmaceuticals

Teva execs aren't sweating newly unveiled pharmaceutical tariffs

Jul 30, 2025 11:11am
The Top Line podcast logo displayed against a stylized background of upward-pointing 3D arrows symbolizing growth on a dark

Teva’s CEO shares ‘Pivot to Growth’ progress

Jun 27, 2025 9:00am
sales sales increase

Teva forecasts $5B-plus in innovative drug sales by 2030

May 30, 2025 7:20am
Neurocrine

Neurocrine's Ingrezza guidance spooks investors

Feb 10, 2025 9:13am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings